Delivery of Long Non-coding RNA NEAT1 by Peripheral Blood Monouclear Cells-Derived Exosomes Promotes the Occurrence of Rheumatoid Arthritis via the MicroRNA-23a/MDM2/SIRT6 Axis-Reference-Cited by-同舟云学术

Delivery of Long Non-coding RNA NEAT1 by Peripheral Blood Monouclear Cells-Derived Exosomes Promotes the Occurrence of Rheumatoid Arthritis via the MicroRNA-23a/MDM2/SIRT6 Axis

Published:2020-09-11 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Rao Yujun,Fang Yuxuan,Tan Wei,Liu Dan,Pang Yubin,Wu Xia,Zhang Chunwang,Li Guoqing

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference47 articles.

1. Sirtuin 6: a review of biological effects and potential therapeutic properties.;Beauharnois;Mol. Biosyst.,2013

2. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration.;Beer;Sci. Rep.,2015

3. Collagen-induced arthritis.;Brand;Nat. Protoc.,2007

4. One year in review 2018: pathogenesis of rheumatoid arthritis.;Calabresi;Clin. Exp. Rheumatol.,2018

5. Genetic and environmental risk factors for rheumatoid arthritis.;Deane;Best Pract. Res. Clin. Rheumatol.,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis;Clinical Rheumatology;2024-02-02

2. Understanding the role of exosomal lncRNAs in rheumatic diseases: a review;PeerJ;2023-12-13

3. Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis;Arthritis Research & Therapy;2023-10-16

4. The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review;Cancers;2023-09-22

5. Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer;Pharmaceutics;2023-07-31